BioVie Inc. (NASDAQ:BIVI) People
People
6ix reads each seat by machine from the page it links to, and can misread one.
| Person | Seat |
|---|---|
| Cuong Do Other companies: Adagene, Inc. (Independent Director · Since at least Mar 18, 2026); Spark I Acquisition Corp. (Director · Oct 5, 2023 – Oct 5, 2023 · Past); Merck & Company, Inc. (EVP & Chief Strategy Officer · Oct 3, 2011 – May 6, 2013 · Past); TE Connectivity plc (SVP, Corp. Strategy & Bus. Dev · Jun 16, 2010 – Sep 15, 2011 · Past) | President & Chief Executive Officer · Since at least Jul 1, 2018 |
| James Paul Lang Other companies: Halozyme Therapeutics, Inc. (Director · Since at least Dec 4, 2025); OptimizeRx Corporation (Director · Since at least Sep 30, 2019) | Director · Since at least Jun 30, 2020 |
| Emily Daniele Other companies: Halozyme Therapeutics, Inc. (Chief Operating Officer · Dec 17, 2025 – Nov 5, 2026 · Past) | Chief Operating Officer · Dec 17, 2025 – Nov 5, 2026 · Past |
| Jim Lang Other companies: Halozyme Therapeutics, Inc. (Director · Since at least Dec 8, 2025) | Independent Director · Since at least Dec 17, 2025 |
| Amy Chappell | Independent Director · Since at least Jul 22, 2025 |
| Chris Reading | Senior Vice President Alzheimer's Disease Program · Since at least Nov 4, 2026 |
| Christopher Reading | EVP Neuroscience R&D · Jul 1, 2021 – Feb 16, 2023 · Past |
| Clarence Ahlem | Senior Vice President Operations · Since at least Jul 1, 2021 |
| David Morse | Chief Regulatory Officer and Senior Vice President · Since at least Nov 5, 2026 |
| Hari Kumar | Director · Jan 2, 2019 – Jun 30, 2020 · Past |
| Jonathan M Adams | EVP Liver Cirrhosis Programs · Jun 30, 2020 – Feb 2, 2022 · Past |
| Joseph M. Palumbo | Executive Vice President, Research & Development and Chief Medical Officer · Since at least Aug 28, 2026 |
| Kameel Farag | Independent Director · Since at least Jul 22, 2025 |
| Michael Sherman | Independent Director · Since at least Nov 5, 2026 |
| Penelope Markham | Senior Vice President Liver Disease and Long COVID Programs · Since at least Nov 1, 2018 |
| Sig Rogich | Independent Director · Since at least Nov 5, 2026 |
| Wendy Kim | Chief Financial Officer · Since at least Nov 5, 2026 |